Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804663 | PMC |
| http://dx.doi.org/10.1186/s40981-017-0140-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Successful Management of Infective Endocarditis Complicated by Pheochromocytoma: A Case Report.
Cureus
March 2025
Department of Cardiovascular Surgery, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, JPN.
Pheochromocytomas present with paroxysmal hypertension due to a sudden release of catecholamines stimulated by radiological contrast media, surgery, or anesthetic agents. This often complicates the maintenance of patient hemodynamics during surgery. A 55-year-old man with a high fever was admitted to a hospital.
View Article and Find Full Text PDFMultidisciplinary Management of Palpebral Melanoma.
Plast Reconstr Surg Glob Open
March 2025
From the Clinica Ziegler, Melanoma and Skin Cancer Unit, Lima, Peru.
Ocular melanoma encompasses the uveal tract, conjunctiva, eyelid, and orbit. Palpebral localization is extremely infrequent, constituting less than 1% of skin melanomas, the main treatment of which is surgical. However, the radicality of the resection is restricted by anatomical location and functional sequelae.
View Article and Find Full Text PDFProtective Effects of Bosentan via Endothelin Receptor Antagonism in Experimental Ischemia-Reperfusion Injury in the Lower Limb of Rats.
Drug Des Devel Ther
March 2025
Gazi University, Faculty of Medicine, Department of Anesthesiology and Reamination, Ankara, Turkey.
Objective: This study aimed to evaluate the protective effects of bosentan, a dual endothelin receptor antagonist, against skeletal muscle ischemia-reperfusion injury (IRI) in rats.
Methods: A total of 24 male Wistar Albino rats were divided into four groups: control (C, n=6), bosentan-treated (B, n=6), ischemia-reperfusion (IR, n=6), and bosentan plus ischemia-reperfusion (B+IR, n=6). Bosentan (10 mg/kg) was administered 30 minutes prior to reperfusion.
Preoperative Management of Catecholamine-Producing Pheochromocytomas and Paragangliomas-Results From a DELPHI Process.
J Endocr Soc
March 2025
Department of Internal Medicine IV, University Hospital Munich, Munich 80336, Germany.
Context: European and German consensus guidelines advocate preoperative therapy with α-adrenoreceptor antagonists in symptomatic patients with catecholamine-producing pheochromocytomas and paragangliomas (PPGLs) to avoid hypertensive crisis during adrenalectomy. This practice has been questioned recently.
Objective: This work aimed to assess current preoperative management of PPGLs across disciplines.
Exploring the Relationship Between Psychiatric Illness and Dermatological Disorders: A Narrative Review.
Cureus
February 2025
Pain Medicine, Fondazione Paolo Procacci, Rome, ITA.
The interplay between psychiatric conditions and dermatological disorders is complex and multifaceted, often resulting in significant challenges for both diagnosis and treatment. This narrative review examines associations between specific psychiatric conditions, trichotillomania, attention deficit hyperactivity disorder, schizophrenia, bipolar disorder, and various dermatological disorders. The present investigation delves into pathophysiological mechanisms, clinical presentations, and management strategies of these comorbid conditions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!